These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37665981)

  • 1. Post-COVID-19 Condition After SARS-CoV-2 Infections During the Omicron Surge vs the Delta, Alpha, and Wild Type Periods in Stockholm, Sweden.
    Hedberg P; Nauclér P
    J Infect Dis; 2024 Jan; 229(1):133-136. PubMed ID: 37665981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between SARS-CoV-2 variants and post COVID-19 condition: findings from a longitudinal cohort study in the Belgian adult population.
    Thi Khanh HN; Cornelissen L; Castanares-Zapatero D; De Pauw R; Van Cauteren D; Demarest S; Drieskens S; Devleesschauwer B; De Ridder K; Charafeddine R; Smith P
    BMC Infect Dis; 2023 Nov; 23(1):774. PubMed ID: 37940843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Omicron Variant Is Associated with a Reduced Risk of the Post COVID-19 Condition and Its Main Phenotypes Compared to the Wild-Type Virus: Results from the EuCARE-POSTCOVID-19 Study.
    Bai F; Santoro A; Hedberg P; Tavelli A; De Benedittis S; de Morais Caporali JF; Marinho CC; Leite AS; Santoro MM; Ceccherini Silberstein F; Iannetta M; Juozapaité D; Strumiliene E; Almeida A; Toscano C; Ruiz-Quiñones JA; Mommo C; Fanti I; Incardona F; Cozzi-Lepri A; Marchetti G;
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).
    Pazukhina E; Rumyantsev M; Baimukhambetova D; Bondarenko E; Markina N; El-Taravi Y; Petrova P; Ezhova A; Andreeva M; Iakovleva E; Bobkova P; Pikuza M; Trefilova A; Abdeeva E; Galiautdinova A; Filippova Y; Bairashevskaia A; Zolotarev A; Bulanov N; DunnGalvin A; Chernyavskaya A; Kondrikova E; Kolotilina A; Gadetskaya S; Ivanova YV; Turina I; Eremeeva A; Fedorova LA; Comberiati P; Peroni DG; Nekliudov N; Genuneit J; Reyes LF; Brackel CLH; Mazankova L; Miroshina A; Samitova E; Borzakova S; Carson G; Sigfrid L; Scott JT; McFarland S; Greenhawt M; Buonsenso D; Semple MG; Warner JO; Olliaro P; Osmanov IM; Korsunskiy AA; Munblit D;
    BMC Med; 2024 Feb; 22(1):48. PubMed ID: 38302974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts.
    Ballouz T; Menges D; Kaufmann M; Amati R; Frei A; von Wyl V; Fehr JS; Albanese E; Puhan MA
    PLoS One; 2023; 18(2):e0281429. PubMed ID: 36812215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between virus variants, vaccination, previous infections, and post-COVID-19 risk.
    Diexer S; Klee B; Gottschick C; Xu C; Broda A; Purschke O; Binder M; Frese T; Girndt M; Hoell JI; Moor I; Gekle M; Mikolajczyk R
    Int J Infect Dis; 2023 Nov; 136():14-21. PubMed ID: 37634619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.
    Xie Y; Choi T; Al-Aly Z
    JAMA Intern Med; 2023 Jun; 183(6):554-564. PubMed ID: 36951829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes during and beyond different COVID-19 critical illness variant periods compared with other lower respiratory tract infections.
    Hedberg P; Baltzer N; Granath F; Fored M; Mårtensson J; Nauclér P
    Crit Care; 2023 Nov; 27(1):427. PubMed ID: 37932793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognosis at 1.5 years after infection with wild-type strain of SARS-CoV-2 and Alpha, Delta, as well as Omicron variants.
    Agergaard J; Gunst JD; Schiøttz-Christensen B; Østergaard L; Wejse C
    Int J Infect Dis; 2023 Dec; 137():126-133. PubMed ID: 37907167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study.
    Gottlieb M; Wang RC; Yu H; Spatz ES; Montoy JCC; Rodriguez RM; Chang AM; Elmore JG; Hannikainen PA; Hill M; Huebinger RM; Idris AH; Lin Z; Koo K; McDonald S; O'Laughlin KN; Plumb ID; Santangelo M; Saydah S; Willis M; Wisk LE; Venkatesh A; Stephens KA; Weinstein RA;
    Clin Infect Dis; 2023 Jun; 76(11):1930-1941. PubMed ID: 36705268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of post-COVID symptoms of the SARS-CoV-2 Delta and Omicron variants in children: a prospective study.
    Yildirim Arslan S; Avcu G; Sahbudak Bal Z; Arslan A; Ozkinay FF; Kurugol Z
    Eur J Pediatr; 2023 Oct; 182(10):4565-4571. PubMed ID: 37526704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post COVID-19 condition diagnosis: A population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection.
    Hedberg P; Granath F; Bruchfeld J; Askling J; Sjöholm D; Fored M; Färnert A; Naucler P
    J Intern Med; 2023 Feb; 293(2):246-258. PubMed ID: 36478477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations.
    Canas LS; Molteni E; Deng J; Sudre CH; Murray B; Kerfoot E; Antonelli M; Rjoob K; Capdevila Pujol J; Polidori L; May A; Österdahl MF; Whiston R; Cheetham NJ; Bowyer V; Spector TD; Hammers A; Duncan EL; Ourselin S; Steves CJ; Modat M
    Lancet Digit Health; 2023 Jul; 5(7):e421-e434. PubMed ID: 37202336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of post-COVID-19 symptoms in patients infected with the SARS-CoV-2 variants delta and omicron-results of the Cross-Sectoral Platform of the German National Pandemic Cohort Network (NAPKON-SUEP).
    Hopff SM; Appel KS; Miljukov O; Schneider J; Addo MM; Bals R; Bercker S; Blaschke S; Bröhl I; Büchner N; Dashti H; Erber J; Friedrichs A; Geisler R; Göpel S; Hagen M; Hanses F; Jensen BO; Keul M; Krawczyk A; Lorenz-Depiereux B; Meybohm P; Milovanovic M; Mitrov L; Nürnberger C; Obst W; Römmele C; Schäfer C; Scheer C; Scherer M; Schmidt J; Seibel K; Sikdar S; Tebbe JJ; Tepasse PR; Thelen P; Vehreschild MJGT; Weismantel C; Vehreschild JJ
    Infection; 2024 Dec; 52(6):2253-2267. PubMed ID: 38700656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection Rate of SARS-CoV-2 in Asymptomatic Healthcare Workers, Sweden, June 2022.
    Blom K; Havervall S; Marking U; Norin NG; Bacchus P; Groenheit R; Bråve A; Thålin C; Klingström J
    Emerg Infect Dis; 2022 Oct; 28(10):2119-2121. PubMed ID: 35997692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower prevalence of post-Covid-19 Condition following Omicron SARS-CoV-2 infection.
    de Bruijn S; van Hoek AJ; Mutubuki EN; Knoop H; Slootweg J; Tulen AD; Franz E; van den Wijngaard CC; van der Maaden T
    Heliyon; 2024 Apr; 10(7):e28941. PubMed ID: 38617937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceived Cognitive Deficits in Patients With Symptomatic SARS-CoV-2 and Their Association With Post-COVID-19 Condition.
    Liu TC; Yoo SM; Sim MS; Motwani Y; Viswanathan N; Wenger NS
    JAMA Netw Open; 2023 May; 6(5):e2311974. PubMed ID: 37145596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.